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Gas-liquid chromatography of enriched bovine brain extract revealed the occurrence of several sulfur-con- 
taining compounds. By co-chromatography with authentic product and by mass-spectrometric analysis, one 
of these compounds has been identified as 1,4-thiomorpholine-3,5-dicarboxylic a id (TMDA). The possible 
derivation of TMDA from lanthionine is discussed. This represents the second S-containing cyclic imino 
acid so far discovered in a mammalian brain whose physiological significance has not yet been explored. 
1,4-Thiomorpholine-3,5-dicarboxylic acid Brain 
1. INTRODUCTION 2. EXPERIMENTAL 
Either oxidative [1,2] or transaminative [3,5] 
deamination of L-cystathionine has been found to 
yield the mono-keto derivative which spontaneous- 
ly cyclizes into the internal ketimine form [6]. L- 
Cystine, L-lanthionine and L-aminoethylcysteine 
behave similarly [1,6]. The reduced form of 
cystathionine ketimine, simply named cyclothi- 
onine, has been detected in the extracts of bovine 
brain analyzed by gas-mass pectrometry [7]. Gas- 
liquid chromatography of bovine brain extracts, 
using a flame photometric detector for sulfur, 
revealed the presence of several sulfur-containing 
compounds [7] worthy of investigation. Here we 
present evidence for the identification of one of 
these compounds as the cyclic imino acid 1,6thio- 
morpholine-3,5-dicarboxylic acid (TMDA), i.e., 
the reduced form of lanthionine ketimine (see 
fig. 1). 
2.1. Materials 
Bovine brains including cerebellum and brain 
stem were obtained from the local slaughterhouse 
and worked out as soon as possible. TMDA was 
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Fig.1. A possible route for the derivation of TMDA 
from lanthionine. An alternative route is the formation 
of the ketimine through the &replacement of cysteine or 
serine using mercaptopyruvate as substituent. 
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prepared by interacting L-cysteine with Br-pyruvic 
acid to yield lanthionine ketimine [8] which was 
then reduced by NaBH4 as reported earlier [9]. The 
isomer 1,3-thiomorpholine-2,4-dicarboxylic acid 
was prepared by interacting DL-homocysteine with 
glyoxylic acid (to be published). Other products 
were of the best commercial source. 
2.2. Enrichment procedure 
Owing to the low content of TMDA it was found 
necessary to submit the brain extracts to an enrich- 
ment procedure before the analyses. The pro- 
cedure was identical to that described for the 
enrichment of cyclothionine [7]. In a preliminary 
experiment 5 mg authentic TMDA were added to 
a brain homogenate and extracted as indicated in 
171. The final extract was subjected to quantitative 
gas-liquid chromatography [lo] which indicated a 
total recovery of the added compound. The pro- 
cedure reported for cyclothionine was thus found 
suitable also for the enrichment of TMDA. 
2.3. Identification procedures 
Gas-liquid chromatography of synthetic TMDA 
and related compounds has been described [lo]. In 
this study we made use of a Perkin-Elmer Sigma 
300 chromatograph provided with a flame 
photometric analyzer for sulfur. The 120 cm x 
2 mm i.d. glass column was packed with 10% 
OV-17 on Chromosorb W HP DMCS 100-120 
mesh. Temperatures were 200°C for the column, 
and 220°C for the injector and the detector. Flow 
rates were 25 ml/min for Nz carrier gas, 
65 ml/min for Hz and 110 ml/min for air. Gas- 
chromatographic-mass pectral analyses were per- 
formed on a Pye Unicam gas chromatograph con- 
nected to an LKB 2091 low-resolution mass spec- 
trometer equipped with a PDP 11 digital com- 
puter. Chromatographic separation was carried 
out on a 25 x 0.2 mm i.d. fused silica capillary col- 
umn with OV-101 as stationary phase. The flow 
rate of helium carrier gas was 0.6 ml/min. The col- 
umn temperature was programmed from 120 to 
250°C at a rate of 8’C/min; injector temperature 
was 250°C; the molecular separator temperature 
was 260°C. Mass spectrometer experimental con- 
ditions were: ionization mode, E.I.; electron 
energy, 70 eV; ion source, 250°C; ion source 
vacuum, 0.5 x 10e6 mmHg. 
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3. RESULTS 
Fig.2 shows the gas liquid chromatogram of the 
final brain extract corresponding to approx. 100 g 
bovine brain. It shows the presence of one large 
peak followed by a shoulder exhibiting the same 
retention times as authentic TMDA. It also shows 
the presence of the 2 peaks of cyclothionine (peaks 
b), with a longer retention time as identified earlier 
[7]. The double peak of TMDA (in the present 
case, a peak and a shoulder) is due to the dimethyl 
ester (the large peak) and to the trimethyl 
derivative (the shoulder), the latter produced by 
the partial methylation of the imino nitrogen by 
the diazomethane reagent as reported [lo]. The 
isomer 1,3-thiomorpholine-2,4-dicarboxylic acid 
exhibited a different elution time and was 
eliminated as a possible candidate for the iden- 
tification of peak a. 
The main peaks of the endogenous and synthetic 
TMDA were submitted to mass spectrometry giv- 
RETENTION TIME (min) 
Fig.2. Gas-liquid chromatography using a flame 
photometric detector for sulfur of enriched bovine brain 
extract. See text for details. 4, bovine brain extract. B, 
1 ,ug authentic TMDA. C, A + B. Peaks: a, TMDA; b, 
cyclothionine. The sample of brain extract used for A 
and C corresponds to approx. 100 g wet brain. 
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Fig.3. Mass spectrum of the main peak of bovine brain 
TMDA, separated as indicated in fig.ZA, compared with 
the mass spectrum of the same peak of authentic 
TMDA, separated as in fig.2B. m/z = 219 is M+, the 
molecular ion; m/z = 160 is M+ less -COOCH3; m/z = 
100 is M+ less 2 -COOCHj, less H. 
ing the fragmentation patterns in fig.3. The 
molecular ion M+ (m/z = 219), accompanied by 
the natural isotopic congeners M+ + 1 and M+ + 2, 
is evident in both patterns. The fragmentations are 
very similar giving an overall superimposable pic- 
ture. Some recognizable fragments are indicated in 
the legend to fig.3. 
The identical chromatographic behaviour, 
presence of sulfur, identical M+ and identical 
fragmentation support the identity of endogenous 
TMDA with the synthetic compound. A rough 
quantitative evaluation of TMDA contained in the 
brain gives a value of 1 pg per cent g brain. This 
value, however, is largely indicative because great 
variations have been observed between different 
extracts. Accurate quantitation of TMDA and 
cyclothionine must await a more sensitive and 
simpler method of analysis, which we are at pre- 
sent working on. 
4. DISCUSSION 
After cyclothionine [7], TMDA is the second S- 
containing cyclic imino acid so far discovered in 
brain. While the biosynthesis of cyclothionine is 
easily amenable to an enzymatic conversion of 
cystathionine, which is present in large amounts in 
mammalian brains [ 111, the biosynthesis of TMDA 
is much more difficult to understand. Apart from 
its possible external source, the monodeamination 
of lanthionine followed by its cyclization and 
reduction, as outlined in fig. 1, could be a plausible 
mechanism. Enzymatic deamination and cycliza- 
tion of lanthionine have been reported [8]. Lan- 
thionine, however, is a rare amino acid found as 
such only occasionally in biological material 
[12-141, being known more as a product of 
denaturation of cystine-containing proteins [ 151 
than as a metabolic compound. The enzymatic 
production of lanthionine was described, in 
Braunstein’s laboratory in 1969, through the ac- 
tion of serine sulfhydrase [16] but has never been 
studied in detail since then. Apart from the deriva- 
tion from lanthionine, other paths could be fol- 
lowed for the production of TMDA. For instance 
the &replacement of serine or cysteine by some 
unspecific lyase [17] using mercaptopyruvate as 
substituent could produce lanthionine ketimine 
which when reduced yields TMDA. 
A point of relevance which stems from the pre- 
sent and previous work [7] is the occurrence in 
brain of acidic N-S containing 7- and (S-membered 
rings suggestive of a possible functional role for 
these compounds totally ignored at present. 
ACKNOWLEDGEMENTS 
We thank Professor L. Boniforti of the Istituto 
Superiore di Sanita for the mass-spectrometric 
analyses and for helpful discussion. We thank also 
Dr M. Achilli for technical collaboration. This 
work has been supported in part by funds of the 
Minister0 della Pubblica Istruzione. 
REFERENCES 
HI 
PI 
[31 
[41 
Cavallini, D., Ricci, G., Federici, G., Costa, M., 
Pensa, B., Matarese, R.M. and Achilli, M. (1982) 
in: Structure and Function Relationships in 
Biochemical Systems (Bossa, F. et al. eds) 
pp.359-367, Plenum, New York. 
Ricci, G., Santoro, L., Achilli, M., Matarese, 
R.M., Nardini, M. and Cavallini, D. (1983) J. Biol. 
Chem. 258, 10511-10517. 
Costa, M., Pensa, B. and Cavallini, D. (1984) 
IRCS Med. Sci. 12, 468-469. 
Cavallini, D., Costa, M., Pensa, B. and Coccia, R. 
(1985) Biochem. Int. 10, 641-646. 
249 
Volume 192. number 2 FEBS LETTERS November 1985 
[5] Costa, M., Pensa, B., Blarzino, C. and Cavallini, 
D. (1985) Physiol. Chem. Phys. 17, 107-111. 
[6] Cavallini, D., Ricci, G. and Federici, G. (1983) in: 
Sulfur Amino Acids (Kuriyama, K. et al. eds) 
pp.355-363, Alan Liss, New York. 
[7] Cavallini, D., Pecci, L., Matarese, R.M., Ricci, G. 
and Achilli, M. (1985) J. Biol. Chem., in press. 
[8] Ricci, G., Federici, G., Lucente, G., Achilli, M. 
and Cavallini, D. (1982) Physiol. Chem. Phys. 14, 
193-199. 
[9] Ricci, G., Nardini, M., Caccurri, A.M. and 
Federici, G. (1983) Biochim. Biophys. Acta 748, 
40-47. 
[lo] Matarese, R.M., Pecci, L., Ricci, G. and Cavallini, 
D. (1984) J. Chromatogr. 294, 413-418. 
[II] Tallan, H.H., Moore, S. and Stein, W.H. (1958) J. 
Biol. Chem. 230, 707-716. 
[12] Sloane, N.H. and Untch, K.G. (1966) Biochemistry 
5, 2658-2665. 
[13] Rao, D.R., Ennor, A.H. and Thorpe, B. (1967) 
Biochemistry 6, 1208-1216. 
[ 141 Wadman, S.K., De Bree, P.K. and Kamerling, J.P. 
(1978) Clin. Chim. Acta 82, 281-284. 
[15] Dowling, L.M. and MacLaren (1965) Biochim. 
Biophys. Acta 100, 293-294. 
[16] Braunstein, A.E., Goryachenkova, E.V. and Lac, 
N.D. (1969) Biochim. Biophys. Acta 171, 366-368. 
[17] Braunstein, A.E. and Goryachenkova, E.V. (1984) 
Adv. Enzymol. 56, l-89. 
250 
